Current Fellows in the Integrative Tumor Epidemiology Branch

Ms. Barnao investigates the role of co-occurring clonal hematopoiesis on various phenotypes, such as hematologic parameters and malignancies.

Dr. Bergeron examines associations between social and economic factors, breast cancer risk, and tumor heterogeneity.

Dr. Booker investigates molecular and social factors that contribute to breast cancer disparities.

Dr. Feng studies the etiology of breast cancer, while exploring the associated risk factors and heterogeneity across different populations.

Dr. Harris studies how breast cancer risk factors impact tumor biology, microenvironment, and outcomes.

Garrett Hendley examines the interplay between various risk factors in breast cancer.

Dr. Kelly studies early somatic events in healthy cells and the contribution of germline and environmental factors to their potential progression to cancer.

Mr. Khandekar analyzes copy number variation and structural variants in normal and tumor genomes.

Dr. Lee is studying tumor evolution of lung cancer from never-smokers through multi-omic analysis and epidemiologic assessment.

Dr. Li studies the role of epigenetic changes in lung cancer in non-smokers.

Ms. Luhar investigates how stromal architecture and immune landscape composition contribute to breast cancer progression.

Ms. Miraftab creates new global contacts and reviews clinical/pathological data for the Sherlock-Lung Study.

Ms. Mitra works on epidemiological studies in health disparities and female cancers.

Dr. Saha uses artificial intelligence and machine-learning to investigate the etiology and prognosis of cancers.

Dr. Sajal investigates the roles of proteins as mediators of the effects of various risk factors on kidney cancer.

Ms. Shahrour investigates the genetic and clinical determinants of melanoma risk and progression.

Ms. Tran works on research into melanoma risk in the Mediterranean.

Dr. Tran uses pathology and radiology data for risk classifications for lung cancer in never-smokers.

Ms. White is researching breast cancer etiology in the Ghana Breast Health Study.

Dr. Young investigates early-stage clonal chromosomal alterations in leukocytes and their potential relevance for hematological cancer risk.

Dr. Zhao investigates the etiology and progression of lung cancer in never smokers through a comprehensive genomic analysis and clinical and epidemiologic assessment.

Dr. Zamani examines the role of germline variants in subsequent cancer risk among childhood cancer survivors and characterizes the genomic landscape of thyroid malignancies.